Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Axon Enterprise Inc ha un obiettivo di prezzo di consenso pari a $681, stabilito in base alle ultime valutazioni degli analisti di 20. Le ultime 3 valutazioni degli analisti sono state rilasciate da B of A Securities, Craig-Hallum y Raymond James il agosto 6, 2025, agosto 5, 2025 y agosto 5, 2025. Con un obiettivo di prezzo medio di $918.33 tra le B of A Securities, Craig-Hallum y Raymond James, c'è un implicito 21.52% upside per Axon Enterprise Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
08/06/2025 | 32.32% | B of A Securities | $895 → $1000 | Maintains | Buy | |||
08/05/2025 | 19.09% | Craig-Hallum | → $900 | Upgrade | Hold → Buy | |||
08/05/2025 | 13.14% | Raymond James | $645 → $855 | Maintains | Outperform | |||
08/05/2025 | 11.15% | UBS | $820 → $840 | Maintains | Neutral | |||
08/05/2025 | 15.12% | Needham | $820 → $870 | Maintains | Buy | |||
07/22/2025 | 9.17% | JMP Securities | $725 → $825 | Maintains | Market Outperform | |||
07/17/2025 | 12.47% | JP Morgan | $730 → $850 | Maintains | Overweight | |||
07/16/2025 | 8.51% | UBS | → $820 | Initiates | → Neutral | |||
07/08/2025 | — | Wolfe Research | — | Initiates | → Outperform | |||
06/04/2025 | 18.43% | B of A Securities | $750 → $895 | Maintains | Buy | |||
05/14/2025 | 9.83% | Goldman Sachs | $730 → $830 | Maintains | Buy | |||
05/09/2025 | -2.74% | Barclays | $726 → $735 | Maintains | Overweight | |||
05/08/2025 | -0.76% | Needham | $600 → $750 | Maintains | Buy | |||
04/23/2025 | -20.61% | Needham | $600 → $600 | Reiterates | Buy → Buy | |||
02/27/2025 | -3.93% | Barclays | $585 → $726 | Maintains | Overweight | |||
02/26/2025 | -4.07% | Citizens Capital Markets | $725 → $725 | Reiterates | Market Outperform → Market Outperform | |||
02/26/2025 | -20.61% | Needham | $600 → $600 | Reiterates | Buy → Buy | |||
02/20/2025 | -17.3% | Craig-Hallum | → $625 | Downgrade | Buy → Hold | |||
02/04/2025 | -4.07% | JMP Securities | $610 → $725 | Maintains | Market Outperform | |||
01/27/2025 | -7.37% | Goldman Sachs | $500 → $700 | Maintains | Buy | |||
01/08/2025 | -7.37% | TD Cowen | → $700 | Initiates | → Buy | |||
12/06/2024 | 5.86% | Baird | $600 → $800 | Maintains | Outperform | |||
12/03/2024 | -7.37% | Morgan Stanley | $500 → $700 | Upgrade | Equal-Weight → Overweight | |||
11/11/2024 | -22.59% | Barclays | $387 → $585 | Maintains | Overweight | |||
11/11/2024 | -27.22% | Northland Capital Markets | $365 → $550 | Maintains | Outperform | |||
11/08/2024 | -19.28% | JMP Securities | $500 → $610 | Maintains | Market Outperform | |||
11/08/2024 | -20.61% | Needham | $525 → $600 | Maintains | Buy | |||
11/08/2024 | -20.61% | Baird | $460 → $600 | Maintains | Outperform | |||
11/04/2024 | -39.13% | Baird | $440 → $460 | Maintains | Outperform | |||
10/31/2024 | -33.84% | JMP Securities | $430 → $500 | Maintains | Market Outperform | |||
10/23/2024 | -41.65% | Goldman Sachs | $385 → $441 | Maintains | Buy | |||
10/22/2024 | -30.53% | Needham | $400 → $525 | Maintains | Buy | |||
09/12/2024 | -43.1% | JMP Securities | $375 → $430 | Maintains | Market Outperform | |||
09/10/2024 | -47.07% | Baird | $360 → $400 | Maintains | Outperform | |||
09/09/2024 | -50.38% | JMP Securities | $375 → $375 | Reiterates | Market Outperform → Market Outperform | |||
08/08/2024 | -51.7% | Northland Capital Markets | $330 → $365 | Maintains | Outperform | |||
08/07/2024 | -50.38% | JMP Securities | $375 → $375 | Reiterates | Market Outperform → Market Outperform | |||
08/07/2024 | -48.79% | Barclays | $381 → $387 | Maintains | Overweight | |||
08/07/2024 | -50.25% | Craig-Hallum | $370 → $376 | Maintains | Buy | |||
08/07/2024 | -52.36% | Baird | $355 → $360 | Maintains | Outperform | |||
08/07/2024 | -47.07% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
07/17/2024 | -49.06% | Jefferies | → $385 | Initiates | → Buy | |||
07/17/2024 | -49.72% | B of A Securities | → $380 | Initiates | → Buy | |||
05/08/2024 | -49.58% | Barclays | $308 → $381 | Maintains | Overweight | |||
05/07/2024 | -50.38% | JMP Securities | $375 → $375 | Reiterates | Market Outperform → Market Outperform | |||
05/07/2024 | -47.07% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
05/07/2024 | -51.04% | Craig-Hallum | $325 → $370 | Maintains | Buy | |||
05/01/2024 | -50.38% | JMP Securities | $320 → $375 | Maintains | Market Outperform | |||
04/26/2024 | -58.98% | Morgan Stanley | $285 → $310 | Maintains | Equal-Weight | |||
04/24/2024 | -47.07% | Needham | $400 → $400 | Reiterates | Buy → Buy | |||
04/11/2024 | -51.7% | JP Morgan | $330 → $365 | Maintains | Overweight | |||
04/10/2024 | -47.07% | Needham | $315 → $400 | Maintains | Buy | |||
03/13/2024 | -49.72% | Argus Research | → $380 | Initiates | → Buy | |||
02/29/2024 | -59.24% | Barclays | $296 → $308 | Maintains | Overweight | |||
02/28/2024 | -62.29% | Morgan Stanley | $250 → $285 | Maintains | Equal-Weight | |||
02/28/2024 | -55.14% | Goldman Sachs | $297 → $339 | Maintains | Buy | |||
02/28/2024 | -56.33% | JP Morgan | $285 → $330 | Maintains | Overweight | |||
02/28/2024 | -58.32% | Needham | $240 → $315 | Maintains | Buy | |||
02/22/2024 | -60.3% | Baird | $260 → $300 | Maintains | Outperform | |||
02/06/2024 | -62.29% | JMP Securities | $250 → $285 | Maintains | Market Outperform | |||
02/02/2024 | -68.24% | Needham | $240 → $240 | Reiterates | Buy → Buy | |||
01/02/2024 | -60.83% | Barclays | $247 → $296 | Maintains | Overweight | |||
11/08/2023 | -69.17% | Raymond James | $223 → $233 | Maintains | Outperform | |||
09/29/2023 | -68.9% | JMP Securities | → $235 | Reiterates | Market Outperform → Market Outperform | |||
08/22/2023 | -69.57% | Morgan Stanley | → $230 | Initiates | → Equal-Weight | |||
08/11/2023 | -68.9% | Northland Capital Markets | $227 → $235 | Maintains | Outperform | |||
08/09/2023 | -68.37% | Barclays | $256 → $239 | Maintains | Overweight | |||
08/09/2023 | -68.24% | Needham | → $240 | Reiterates | Buy → Buy | |||
05/11/2023 | -68.24% | Baird | $237 → $240 | Maintains | Outperform | |||
05/11/2023 | -68.77% | JP Morgan | → $236 | Upgrade | Neutral → Overweight | |||
05/10/2023 | -68.9% | JMP Securities | → $235 | Reiterates | → Market Outperform | |||
05/10/2023 | -59.11% | Credit Suisse | $300 → $309 | Maintains | Outperform | |||
05/10/2023 | -68.24% | Needham | → $240 | Reiterates | → Buy | |||
05/10/2023 | -66.13% | Barclays | $222 → $256 | Maintains | Overweight | |||
04/14/2023 | -68.9% | JMP Securities | → $235 | Reiterates | → Market Outperform | |||
04/13/2023 | -68.24% | Needham | → $240 | Reiterates | → Buy | |||
04/11/2023 | -60.3% | Credit Suisse | $237 → $300 | Maintains | Outperform | |||
03/08/2023 | -65.2% | Goldman Sachs | → $263 | Initiates | → Buy | |||
03/02/2023 | -70.62% | Barclays | $177 → $222 | Maintains | Overweight | |||
03/02/2023 | -70.36% | JP Morgan | → $224 | Downgrade | Overweight → Neutral | |||
03/01/2023 | -68.64% | Baird | $200 → $237 | Maintains | Outperform | |||
03/01/2023 | -68.64% | Credit Suisse | $200 → $237 | Maintains | Outperform | |||
03/01/2023 | -68.24% | Needham | → $240 | Reiterates | → Buy | |||
02/17/2023 | -70.49% | Raymond James | → $223 | Downgrade | Strong Buy → Outperform | |||
02/01/2023 | -68.9% | JMP Securities | $195 → $235 | Maintains | Market Outperform | |||
01/10/2023 | -73.54% | Credit Suisse | $152 → $200 | Maintains | Outperform | |||
12/13/2022 | -79.49% | Morgan Stanley | $130 → $155 | Maintains | Equal-Weight | |||
11/09/2022 | -82.8% | Morgan Stanley | $120 → $130 | Maintains | Equal-Weight | |||
11/09/2022 | -79.89% | Credit Suisse | $142 → $152 | Maintains | Outperform | |||
11/09/2022 | -73.54% | Needham | $130 → $200 | Maintains | Buy | |||
09/15/2022 | -80.55% | Barclays | → $147 | Initiates | → Overweight |
El último precio objetivo de Axon Enterprise (NASDAQ:AXON) fue comunicado por B of A Securities el agosto 6, 2025. La firma de analistas fijó un precio objetivo para $1000.00 que espera AXON a rise dentro de 12 meses (un posible 31.72% upside). 35 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Axon Enterprise (NASDAQ:AXON) fue proporcionada por B of A Securities, y Axon Enterprise mantuvo su buy calificación.
La última revisión al alza de Axon Enterprise Inc se produjo en agosto 5, 2025, cuando Craig-Hallum elevó su precio objetivo a $900. Craig-Hallum anteriormente tenía a hold para Axon Enterprise Inc.
La última revisión a la baja de Axon Enterprise Inc se produjo en febrero 20, 2025, cuando Craig-Hallum cambió su precio objetivo de N/A a $625 para Axon Enterprise Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Axon Enterprise, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Axon Enterprise se registró el agosto 6, 2025, por lo que la próxima calificación estará disponible en torno al agosto 6, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Axon Enterprise (AXON) fue un mantuvo con un precio objetivo de $895.00 a $1000.00. El precio actual al que cotiza Axon Enterprise (AXON) es de $759.19, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.